shortagewatch

Home / Anti-infectives / Cefotaxime

ATC J01DD01 · Antibacterials for Systemic Use

Cefotaxime shortage

As of 31 Oct 2026, Cefotaxime has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Austria), covering 9 products.

Countries4/5
Products9packs or presentations
Short since24 Aug 202514 months ago
Earliest return13 Nov 2026company estimate
No return date3products
Main reasonCommercial decision or withdrawal
Germany2 packs shortItaly4 packs shortSpain2 packs shortAustria1 pack shortBelgiumNo reported shortage

Timeline

GermanyItalySpainAustria
20262028202920302031Cefotaxim-saar 1 g Pulver zur Herstellung eiCefotaxim-saar 1 g Pulver zur Herstellung einer Injektions- bzw. InfusionslösungCefotaxim-saar 2 g Pulver zur Herstellung eiCefotaxim-saar 2 g Pulver zur Herstellung einer Injektions- bzw. InfusionslösungBATIXIMBATIXIMCEFOTAXIMA TEVACEFOTAXIMA TEVACEFOTAXIMA SALA 1G POLVO PARA SOLUCION INYECCEFOTAXIMA SALA 1G POLVO PARA SOLUCION INYECTABLE EFG, 100 vialesCEFOTAXIMA SALA 2 G POLVO PARA SOLUCION INYECEFOTAXIMA SALA 2 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIÓN EFG, 50 vialesCefotaxim-MIP 2 g - Pulver zur Herstellung eCefotaxim-MIP 2 g - Pulver zur Herstellung einer Injektions- oder Infusionslösung, 10 Stücktoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DECefotaxim-saar 1 g Pulver zur Herstellung einer Injektions- bzw. InfusionslösungMIP Pharma GmbH1 Sep 202630 Nov 2026Manufacturing problem
Herstellerwechsel
DECefotaxim-saar 2 g Pulver zur Herstellung einer Injektions- bzw. InfusionslösungMIP Pharma GmbH1 Sep 202630 Nov 2026Manufacturing problem
Herstellerwechsel
ITBATIXIMSO.SE.PHARM S.R.L. SOCIETA' DI SERVIZIO PER L'INDUSTRIA FARMACEUTICA ED AFFINI24 Aug 2025not givenCommercial decision or withdrawal
Motivi commerciali
ITCEFOTAXIMA TEVATEVA ITALIA S.R.L.1 Oct 202631 Jan 2027Commercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale ospedaliero)
ITBATIXIM announcedSO.SE.PHARM S.R.L. SOCIETA' DI SERVIZIO PER L'INDUSTRIA FARMACEUTICA ED AFFINI28 Dec 2026not givenCommercial decision or withdrawal
Motivi commerciali
ITCEFOTAXIMA TEVA announcedTEVA ITALIA S.R.L.1 Feb 2027not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale retail)
ESCEFOTAXIMA SALA 1G POLVO PARA SOLUCION INYECTABLE EFG, 100 vialesLaboratorio Reig Jofre, S.A.6 Apr 202613 Nov 2026Not stated
ESCEFOTAXIMA SALA 2 G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIÓN EFG, 50 vialesLaboratorio Reig Jofre, S.A.23 Jul 202621 Nov 2030Not stated
ATCefotaxim-MIP 2 g - Pulver zur Herstellung einer Injektions- oder Infusionslösung, 10 StückMIP Pharma Austria GmbH5 Aug 202630 Nov 2026Manufacturing problem
Verzögerung in der Freigabe des Fertigproduktes

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Cefixime Ceftazidime Ceftriaxone